Fabrazyme 35 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBN6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,525
Award facts
- Contract value 100% obligated
- $34,524.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,524.54 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fabrazyme 35 mg vials. The award, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated contract SPE2DR, which was awarded on November 13, 2025, with a $500 million ceiling value and completion through December 31, 2036. The PPV-G GEN V program represents part of DLA's broader $30.3 billion pharmaceutical supply strategy designed to support Department of Defense medical facilities worldwide. As a prime vendor contractor, DMS Pharmaceutical Group is authorized to receive delivery orders for a comprehensive range of pharmaceuticals, biologics, and medical consumables to meet recurring military healthcare supply requirements globally. The vendor's established performance on numerous prior delivery orders demonstrates its capability to fulfill specialized pharmaceutical needs across the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FFBN6?
SPE2DR26FFBN6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FFBN6 worth?
The government has obligated $34,525 on SPE2DR26FFBN6.
Is contract SPE2DR26FFBN6 an order under another contract?
Yes. SPE2DR26FFBN6 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBN6 competed?
The extent of competition for SPE2DR26FFBN6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award